Status:
UNKNOWN
Inspiratory Muscle Strength Training in Post-Covid Syndrome
Lead Sponsor:
D'Or Institute for Research and Education
Conditions:
Cardiovascular Abnormalities
Post-COVID-19 Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Patients with post-Covid-19 syndrome are at high risk of developing cardiovascular diseases 12 months after acute infection of COVID-19. We recently revealed that these patients have elevated muscular...
Eligibility Criteria
Inclusion
- Post-COVID-19 syndrome
- Have been diagnosed with COVID-19 by RT-PCR
- Have oxygen saturation ≤ 93% in room air during the acute phase of the COVID-19
- Have received oxygen supply from any device during the acute phase of the COVID-19
- Hospitalization to treat the Covid-19
- Participants in cardiopulmonary rehabilitation or physical conditioning programs
Exclusion
- Pregnant
- History of chronic obstructive pulmonary disease or dependence on oxygen support
- History of cardiovascular and renal diseases and cancer prior to the COVID-19 diagnosis
- Difficulties in moving to the laboratory for assessments
Key Trial Info
Start Date :
October 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06091384
Start Date
October 16 2023
End Date
October 31 2024
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
D'Or Institute of Research and Education
São Paulo, Brazil, 04501-000